NEW YORK (360Dx) – Quidel said today that it has closed its previously announced acquisition of Alere's Triage MeterPro cardiovascular and toxicology business and its B-type natriuretic peptide (BNP) assay business.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.